Skip to content

Drug interactions

Lorlatinib + Perampanel

Severity: Moderate

Lorlatinib and Perampanel: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib induces CYP3A4 and may lower perampanel concentrations, potentially reducing seizure control.

What this interaction means in plain words

Lorlatinib and Perampanel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lorlatinib belongs to Oncology; Perampanel belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Lorlatinib induction of CYP3A4 increases perampanel metabolism.

What to do

Monitor seizure control and consider increasing perampanel dose as with other CYP3A4 inducers, titrating to response and tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lorlatinib and Perampanel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lorlatinib with Perampanel?

MediHelp rates the interaction as moderate. Lorlatinib and Perampanel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lorlatinib induces CYP3A4 and may lower perampanel concentrations, potentially reducing seizure control.

How serious is the interaction between Lorlatinib and Perampanel?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor seizure control and consider increasing perampanel dose as with other CYP3A4 inducers, titrating to response and tolerability.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in